Toggle navigation
Home
Search
Services
Blog
Contact
About
MD Access to Drug Profiles to Reduce Adverse Reactions
Tomkins, Edward L.
Provider Advantage Nw, Inc., Portland, OR, United States
Search 3 grants from Edward Tomkins
Search grants from Provider Advantage Nw, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Transcriptional Elongation Control in Development and Disease
Zinc Finger Genes and Pancreatic Cell Growth
Pramipexole in the Treatment of Tardive Dyskinesia
Cell Surface Interactions in Oral Plaque Bacteria
Evolution and Phylogeny of Geographical Races in the Mimetic Butterflies, Heliconius erato and H. melpomene
Recently added grants:
CD4 T cell control of cytomegalovirus
Virology Core
Wisconsin Infant Study Cohort (WISC)
The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AG012644-02
Application #
2001584
Study Section
Special Emphasis Panel (ZRG1-HUD-2 (01))
Project Start
1994-09-01
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Provider Advantage Nw, Inc.
Department
Type
DUNS #
City
Portland
State
OR
Country
United States
Zip Code
97229
Related projects
NIH 1997
R44 AG
MD Access to Drug Profiles to Reduce Adverse Reactions
Tomkins, Edward L. / Provider Advantage Nw, Inc.
NIH 1996
R44 AG
MD Access to Drug Profiles to Reduce Adverse Reactions
Tomkins, Edward L. / Provider Advantage Nw, Inc.
Comments
Be the first to comment on Edward Tomkins's grant